GUTS_OUT_1 [2025-04-01 08:29:34 -0400] 2315 Bytes | 629 tokens | Cum: 629 tkns (7.86% of 8k)
==========================================================================

We're scouting for winners today. Its 8:29:33 AM on Tue Apr 01, 2025 -0400 and I'm looking at Fractyl Health (GUTS) up to 1.37 from 1.19

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

Here's the first list of news for Fractyl Health:

C1 - Today 07:00AM - Fractyl Health Reports Positive Early Data Showing Revita Has Potential to Prevent Weight Regain After GLP-1 Discontinuation
C2 - Mar-03-25 04:05PM - Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
C3 - Feb-24-25 07:00AM - Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025
C4 - Feb-12-25 09:35AM - After Plunging -19.55% in 4 Weeks, Here's Why the Trend Might Reverse for Fractyl Health, Inc. (GUTS)
C5 - Feb-10-25 03:00AM - Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments
C6 - Jan-31-25 08:01AM - Fractyl Health Announces Increased Focus on Groundbreaking Revita Weight Maintenance and Rejuva Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025
C7 - Jan-13-25 07:00AM - Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort
C8 - Jan-06-25 09:10AM - Heres Why Fractyl Health, Inc. (NASDAQ:GUTS) Is Among the Best Diabetes Stocks to Buy Under $10

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Fractyl Health (GUTS)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

GUTS_OUT_3 [2025-04-01 08:29:39 -0400] 1103 Bytes | 342 tokens | Cum: 973 tkns (12.16% of 8k)
==========================================================================

Showing C1 (chunk 1 of 10): C1:
**Fractyl Health Reports Positive Early Data Showing Revita Has Potential to Prevent Weight Regain After GLP-1 Discontinuation**
Date: Today 07:00AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/04/01/3053157/0/en/Fractyl-Health-Reports-Positive-Early-Data-Showing-Revita-Has-Potential-to-Prevent-Weight-Regain-After-GLP-1-Discontinuation.html

April 01, 2025 07:00 ET| Source:Fractyl Health, Inc.Fractyl Health, Inc.Burlington, MA

New REVEAL-1 study results show early signs of weight maintenance after GLP-1 discontinuation

REMAIN-1 pivotal study now more than 50% enrolled; midpoint data analysis anticipated in Q3 2025

BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (“the Company”), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes (T2D

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

GUTS_OUT_5 [2025-04-01 08:29:40 -0400] 999 Bytes | 280 tokens | Cum: 1355 tkns (16.94% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-01T12:02:00Z - Fractyl'S Revita Shows Evidence Of Weight Maintenance In REVEAL-1 Cohort...
A2 - 2025-04-01T11:21:35Z - Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain Af...
A3 - 2025-04-01T11:00:00Z - Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain Af...
A4 - 2025-04-01T11:17:03Z - Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain Af...
A5 - 2025-03-19T00:00:07Z - Fractyl Health director Ajay Royan purchases $22,979 in common stock By Investing.com...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

GUTS_OUT_7 [2025-04-01 08:29:44 -0400] 1098 Bytes | 297 tokens | Cum: 1654 tkns (20.67% of 8k)
==========================================================================

Showing A1 (chunk 1 of 2): A1:
**Fractyl'S Revita Shows Evidence Of Weight Maintenance In REVEAL-1 Cohort**Date: 2025-04-01Source: {'uri': 'rttnews.com', 'dataType': 'news', 'title': 'RTTNews'}URL: https://www.rttnews.com/3525898/fractyl-s-revita-shows-evidence-of-weight-maintenance-in-reveal-1-cohort.aspxFractyl Health, Inc. (GUTS), Tuesday announced positive early data from the open-label REVEAL-1 cohort of its ongoing REMAIN-1 pivotal study, suggesting that Revita may help prevent weight regain after patients stop GLP-1 drugs.

In the cohort, 15 patients were treated. Of this, 1-month data for the first 7 patients was available, showing an average weight regain of just 1.2 percent compared to about 3 percent typically observed during this period in the previous clinical studies.

Additionally, no safety or tolerability concerns were reported in the fifteen patients.

The metabolic therapeutics company now antic

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

GUTS_OUT_9 [2025-04-01 08:29:45 -0400] 1211 Bytes | 340 tokens | Cum: 2088 tkns (26.10% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-11-26T12:00:00Z - Fractyl Health to Participate in the Upcoming December Conferences
B2 - 2024-10-29T11:00:00Z - Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
B3 - 2024-06-25T11:00:00Z - Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
B4 - 2024-06-24T10:00:00Z - Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
B5 - 2024-06-23T17:30:00Z - Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
B6 - 2024-05-20T10:00:00Z - Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

GUTS_OUT_11 [2025-04-01 08:29:48 -0400] 685 Bytes | 186 tokens | Cum: 2276 tkns (28.45% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Fractyl Health to Participate in the Upcoming December Conferences**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2024/11/26/2987332/0/en/Fractyl-Health-to-Participate-in-the-Upcoming-December-Conferences.htmlFractyl Health, a metabolic therapeutics company, announced that its co-founder and CEO will present at two upcoming investor conferences. The company is focused on developing new approaches to treat obesity and Type 2 Diabetes.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

GUTS_OUT_13 [2025-04-01 08:29:49 -0400] 535 Bytes | 146 tokens | Cum: 2484 tkns (31.05% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-01 8-K Item 7.01 Regulation FD Disclosure.

On April 1, 2025, Fractyl Health, Inc. (the Company) issued the press release furnished as Exhibit 99.1 to this Curr Report on Form 8-K and incorporated herein by reference.

The information contained in Item 7.01 of this Curr Report (...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

GUTS_OUT_15 [2025-04-01 08:29:54 -0400] 906 Bytes | 233 tokens | Cum: 2719 tkns (33.99% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 7.01 Regulation FD Disclosure.

On April 1, 2025, Fractyl Health, Inc. (the Company) issued the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

The information contained in Item 7.01 of this Current Report (including Exhibit 99.1 attached hereto) shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing....

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

GUTS_OUT_17 [2025-04-01 08:30:06 -0400] 7464 Bytes | 2062 tokens | Cum: 4886 tkns (61.08% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+-------------------------+
| Volume: 166,669 | Perf Month: -23.72% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+---------------------+-----------------------+------------------------+-------------------------+
| Avg Volume: 294.26K | Perf Quarter: -42.23% | Short Float: 14.46% | ROE: - |
+---------------------+-----------------------+------------------------+-------------------------+
| Rel Volume: 0.56 | Index: RUT | Short Ratio: 10.25 | ROI: -81.93% |
+---------------------+-----------------------+------------------------+-------------------------+
| RSI (14): 36.85 | Market Cap: 58.22M | Short Interest: 3.02M | Sales Surprise: -70.00% |
+---------------------+-----------------------+------------------------+-------------------------+
| ATR (14): 0.11 | Shs Outstand: 48.76M | Beta: 0.30 | EPS Surprise: -19.54% |
+---------------------+-----------------------+------------------------+-------------------------+
| SMA20: -9.92% | Shs Float: 20.86M | Sales Q/Q: -57.14% | P/E: - |
+---------------------+-----------------------+------------------------+-------------------------+
| SMA50: -21.94% | Inst Own: 34.80% | Sales past 5Y: -4.50% | Earnings: Mar 03 AMC |
+---------------------+-----------------------+------------------------+-------------------------+
| SMA200: -53.70% | Insider Own: 57.37% | Employees: 107 | |
+---------------------+-----------------------+------------------------+-------------------------+
| Perf Week: -8.46% | Insider Trans: -0.83% | Debt/Eq: 2.20 | |
+---------------------+-----------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: FRACTYL HEALTH, INC. (GUTS) by Royan Ajay (Unknown Title) on 2025-03-14
- Common Stock: 17901 shares at $1.2837 (D) Footnote: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 1.22 to 1.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Inside Trans: FRACTYL HEALTH, INC. (GUTS) by Barnes Kelly Ann (Unknown Title) on 2025-03-14
- Common Stock: 31000 shares at $1.2971 (D)

Inside Trans: FRACTYL HEALTH, INC. (GUTS) by SCHULMAN AMY W (Unknown Title) on 2025-03-13
- Common Stock: 8550 shares at $1.1654 (D) Footnote: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 1.165 to 1.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Inside Trans: FRACTYL HEALTH, INC. (GUTS) by BRADLEY WILLIAM (Unknown Title) on 2025-03-13
- Common Stock: 16129 shares at $1.2622 (D) Footnote: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2350 to $1.2900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Inside Trans: FRACTYL HEALTH, INC. (GUTS) by Conaway Samuel (Unknown Title) on 2025-03-13
- Common Stock: 8550 shares at $1.1654 (D) Footnote: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 1.165 to 1.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Inside Trans: FRACTYL HEALTH, INC. (GUTS) by Rajagopalan Harith (Chief Executive Officer) on 2025-02-27
- Stock Option (right to buy): 571491 shares at $0 (D)
- Stock Option (right to buy): 261540 shares at $0 (D)

Inside Trans: FRACTYL HEALTH, INC. (GUTS) by Kieffer Timothy (Chief Scientific Officer) on 2025-02-27
- Stock Option (right to buy): 169700 shares at $0 (D)
- Stock Option (right to buy): 35280 shares at $0 (D)

Inside Trans: FRACTYL HEALTH, INC. (GUTS) by Toomey Sarah (General Counsel) on 2025-02-27
- Stock Option (right to buy): 166200 shares at $0 (D)
- Stock Option (right to buy): 79380 shares at $0 (D)

Inside Trans: FRACTYL HEALTH, INC. (GUTS) by Davidson Lisa (Chief Financial Officer) on 2025-02-27
- Stock Option (right to buy): 174700 shares at $0 (D)
- Stock Option (right to buy): 91500 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.19
Average Volume: 199668.33
30-Day High: 1.59
30-Day Low: 1.19

[Detailed Financials: Q3 2024]
- Total Assets: $126,924,000.0
- Total Liabilities: $76,602,000.0
- Total Equity: $50,322,000.0
- Current Assets: $87,651,000.0
- Current Liabilities: $15,717,000.0

[Income Statement: Q3 2024]
- Revenue: $14,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.48

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-18,090,000.0

[Detailed Financials: Q2 2024]
- Total Assets: $146,437,000.0
- Total Liabilities: $75,682,000.0
- Total Equity: $70,755,000.0
- Current Assets: $106,555,000.0
- Current Liabilities: $14,281,000.0

[Income Statement: Q2 2024]
- Revenue: $43,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.36

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-19,002,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

GUTS_OUT_19 [2025-04-01 08:30:08 -0400] 676 Bytes | 167 tokens | Cum: 5328 tkns (66.60% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

GUTS_IN_21 [2025-04-01 08:30:08 -0400] 126 Bytes | 29 tokens | Cum: 5385 tkns (67.31% of 8k)
==========================================================================

====================================
[2025-04-01 08:30:08] # Analysis Completed
Elapsed Time: 34.86 seconds